Amedeo Smart

Free Medical Literature Service

 

Amedeo

Antiretroviral Therapy
  Free Subscription

Articles published in
Lancet
    February 2026
  1. COLSON AE, Mills AM, Ramgopal MN, Bettacchi C, et al
    Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, dou
    Lancet. 2026;407:611-621.
    >> Share

    November 2025
  2. KARIM QA
    Lessons from Africa: health diplomacy in HIV prevention.
    Lancet. 2025 Nov 4:S0140-6736(25)01976-2. doi: 10.1016/S0140-6736(25)01976.
    >> Share

    October 2025
  3. NDEMBI N, Mercy K, Folayan MO, Abdool Karim SS, et al
    Analysis of mpox in Angola conflates distinct timelines.
    Lancet. 2025;406:e29.
    >> Share

  4. ABDOOL KARIM Q, Mohan J, Bhutta ZA
    Advancing women, maternal, newborn, and child health equity.
    Lancet. 2025 Oct 10:S0140-6736(25)01920-8. doi: 10.1016/S0140-6736(25)01920.
    >> Share

    March 2024
  5. KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al
    Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464.
    >> Share

    December 2023
  6. PAPINENI P
    Directly observed therapy.
    Lancet. 2023;400:2265-2266.
    >> Share

    June 2023
  7. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    >> Share

    October 2022
  8. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    >> Share

    May 2022

  9. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    >> Share

    April 2022
  10. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    >> Share

    March 2022
  11. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

    February 2022
  12. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    >> Share

  13. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016